Products
3579 products
Page:1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36
| Code | Description | Unit |
|---|---|---|
| USP-1478480 | Omeprazole Related Compound B (5-Methoxy-1H-benzimidazol-2-thiol) | 15 mg |
| USP-1586020 | Pyridostigmine Related Compound A (Pyridin-3-yl dimethylcarbamate) | 50 mg |
| USP-1586031 | Pyridostigmine Related Compound B (3-Hydroxy-1-methylpyridin-1-ium bromide) | 10 mg |
| USP-1623783 | Sulbactam Related Compound E ((2S,5R)-6,6-Dibromo-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid 4,4-dioxide) | 15 mg |
| USP-1623794 | Sulbactam Related Compound F ((2S,5R)-6,6-Dibromo-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid) | 15 mg |
| USP-1631511 | Sulfamethoxazole Related Compound A (N-{4-[N-(5-methylisoxazol-3-yl)sulfamoyl]phenyl}acetamide) | 15 mg |
| USP-1631522 | Sulfamethoxazole Related Compound B (4-amino-N-{4-[N-(5-methylisoxazol-3-yl)sulfamoyl]phenyl}benzenesulfonamide | 15 mg |
| USP-1631533 | Sulfamethoxazole Related Compound C (5-methylisoxazol-3-amine) | 15 mg |
| USP-1631566 | Sulfamethoxazole Related Compound F (4-amino-N-(3-methylisoxazol-5-yl)benzenesulfonamide) | 15 mg |
| USP-1643667 | Tenofovir Disoproxil Related Compound F (O-(Ethoxycarbonyloxymethyl)-O-(isopropoxycarbonyloxymethyl)-{(R)-[1-(6-amino-9H-purin-9-yl)propan-2-yloxy]}methylphosphonate fumarate) | 15 mg |
| USP-1672723 | Trandolapril Related Compound E ((2S,3aR,7aS)-1-[N-[(S)-1-Carboxy-3-phenylpropyl]-L-alanyl]hexahydro-2-indolinecarboxylic acid) | 25 mg |
| USP-1699027 | Tropicamide Related Compound B (N-ethyl-2-phenyl-N-(pyridin-4-ylmethyl)acrylamide) | 50 mg |
| USP-1708810 | Valsartan Related Compound E (N-valeryl-N-{[2'-(1H-tetrazole-5-yl)biphenyl-4-yl]methyl}-L-valine methyl ester) | 15 mg |
| USP-1379300 | Melphalan hydrochloride | 100 mg |
| USP-1045938 | Azathioprine Related Compound G (6-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]-9H-purin-2-amine) | 15 mg |
| USP-1045993 | Azathioprine Related Compound A (1-methyl-4-nitro-1H-imidazol-5-amine) | 15 mg |
| USP-1500626 | Pegfilgrastim for Bioassay (COLD SHIPMENT REQUIRED) | each |
| USP-1029534 | Amlodipine Related Compound C (Dimethyl 4-(2-chlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate) | 25 mg |
| USP-1029545 | Amlodipine Related Compound D (3-Ethyl 5-methyl 4-(2-chlorophenyl)-2-{[2-(1,3-dioxoisoindolin-2-yl)ethoxy]methyl}-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate) | 25 mg |
| USP-1029556 | This item has been discontinued - Amlodipine Related Compound E (Diethyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate) | 25 mg |
| USP-1029567 | This item has been discontinued - Amlodipine Related Compound F (Dimethyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate) | 25 mg |
| USP-1029614 | Amlodipine Related Compound K (Ethyl 6-(2-chlorophenyl)-8-methyl-3,4,6,7-tetrahydro-2H-benzo[b][1,4]oxazine-5-carboxylate) | 25 mg |
| USP-1150524 | Cromolyn Related Compound B (Diethyl 5,5'-[(2-hydroxypropane-1,3-diyl)bis(oxy)]bis(4-oxo-4H-chromene-2-carboxylate)) | 25 mg |
| USP-1166149 | This item has been discontinued - Deflazacort Related Compound C (11Beta,21-Dihydroxy-2'-methyl-5'BetaH-pregna-1,4-dieno[17,16-d]oxazole-3,20-dione) | 15 mg |
| USP-1029997 | Ammonium Salts of Phosphatidic Acid (ammonium phosphatides) | 1, 5 g |
| USP-1044345 | Atazanavir System Suitability Mixture (A mixture of Atazanavir sulfate and Atazanavir R, S, S, S,-diastereomer sulfate) | 25 mg |
| USP-1048415 | Lagerstroemia speciosa Leaf Dry Extract | 1 g |
| USP-1082617 | Butyl Cinnamate | 500 mg |
| USP-1097727 | Cefetamet | 15 mg |
| USP-1112423 | Indomethacin Related Compound B (4-Chlorobenzoic acid) | 25 mg |
| USP-1148737 | Corosolic Acid | 50 mg |
| USP-1150115 | Cosyntropin Acetate (alpha1-24-Corticotropin) | 1,69 mg |
| USP-1468465 | Norelgestromin Related Compound A (13-Ethyl-17 -hydroxy-18, 19-dinor-17alpha-pregn-5(6)-en-20-yn-3-one oxime) | 15 mg |
| USP-1179118 | Dexketoprofen Tromethamine | 200 mg |
| USP-1225656 | This item has been discontinued - Doxofylline | 100 mg |
| USP-1265300 | Ethyl 4-nitrobenzoate | 40 mg |
| USP-1269017 | Evening Primrose Oil | 1 g |
| USP-1270774 | Flax Seed Oil | 1 g |
| USP-1282729 | Fondaparinux Sodium System Suitability Mixture A | 2.5 mg |
| USP-1288372 | Ganoderma lucidum Fruiting Body Dry Extract | 1 g |
| USP-1288383 | Ganoderic Acid A | 50 mg |
| USP-1291672 | Ginsenoside Rg1 | 20 mg |
| USP-1291719 | Panax Notoginseng Root and Rhizome Dry Extract | 1 g |
| USP-1335621 | Ibutilide Related Compound A (N-Ethyl-N-heptyl-4-[4-(methylsulfonamido )phenyl]-4-oxobutanamide) | 20 mg |
| USP-1356585 | Ketoprofen Related Compound F (3-(1-Cyanoethyl)benzophenone) | 20 mg |
| USP-1356871 | Hydrogenated Lanolin | 200 mg |
| USP-1357227 | Lamivudine Related Compound A ((2RS,5R)-5-(Cytosine-1-yl)-1 3-oxathiolane-2-carboxylic acid) | 25 mg |
| USP-1381119 | Menaquinone-7 (Vitamin K2) | 3 x 50 mg |
| USP-1537910 | Phytic Acid Solution in Water - 53,6% Phytic acid in Water | 5 mL |
| USP-1544938 | Plastic Additive 2 (Pentaerythrityl tetrakis[3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate]) | 200 mg |
| USP-1544949 | Plastic Additive 3 (2,2' ,2'' ,6, 6' ,6''-Hexa-tert-butyl-4,4' ,4''-[(2,4,6-trimethyl-1 ,3,5-benzenetriyl)trismethylene]triphenol) | 200 mg |
| USP-1544950 | Plastic Additive 4 (Octadecyl 3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate) | 200 mg |
| USP-1544964 | Plastic Additive 5 (Tris(2,4-di-tert-butylphenyl) phosphite) | 200 mg |
| USP-1544971 | Plastic Additive 6 1,3,5-Tris(3,5-di-tert-butyl-4-hydroxybenzyl)-s-triazine-2,4,6(1 H,3H,5H)-trione) | 200 mg |
| USP-1612719 | Tenivastatin Calcium (Calcium (3R,5R)-7-{(1S,2S,6R,8S,8aR)-8-[(2,2-dimethylbutanoyl)oxy]-2,6-dimethyl-1,2,6,7,8,8a-hexahydronaphthalen-1-yl}-3,5-dihydroxyheptanoate (1:2) monohydrate) | 30 mg |
| USP-1649991 | Tetracaine | 50 mg |
| USP-1650017 | Tetracaine Related Compound B (4-(Butylamino)benzoic acid) | 25 mg |
| USP-1686411 | Trigonelline (1-Methylpyridinium-3-carboxylate monohydrate) | 20 mg |
| USP-1699016 | Tropicamide Related Compound A (N-(pyridin-4-ylmethyl)ethanamine) | 100 mg |
| USP-1042270 | Arachidyl Alcohol | 125 mg |
| USP-1044334 | Atazanavir Sulfate | 200 mg |
| USP-1076057 | Borage Seed Oil | 1 g |
| USP-1078846 | Bupropion Hydrobromide | 200 mg |
| USP-1112311 | Chlorobenzhydryl Piperazine | 75 mg |
| USP-1211287 | 6,6'-Dinicotinic Acid | 50 mg |
| USP-1268919 | Eucalyptus Oil | 1 g |
| USP-1308550 | L-Histidine Monohydrochloride Monohydrate | 200 mg |
| USP-1324308 | Hydroxocobalamin Acetate | 150 mg |
| USP-1359958 | Levocetirizine Amide | 75 mg |
| USP-1359969 | Levocetirizine Dihydrochloride | 200 mg |
| USP-1367639 | Linezolid R-Isomer (N-{[(R)-3-(3-Fluoro-4-morpholinophenyl)-2-oxo-5-oxazolidinyl]methyl}acetamide) | 20 mg |
| USP-1367699 | Linolenyl Alcohol | 5 x 30 mg |
| USP-1424084 | 9-Methylacridine | 25 mg |
| USP-1424550 | Methylcobalamin | 2 x150 mg |
| USP-1430815 | 6-Methylnicotinic Acid | 50 mg |
| USP-1478731 | cis-Ormeloxifene Hydrochloride (1-(2-{4-[(3SR,4RS)-7-Methoxy-2,2-dimethyl-3-phenylchroman-4-yl]phenoxy}ethyl)pyrrolidine hydrochloride) | 25 mg |
| USP-1483425 | Oxiconazole Nitrate | 200 mg |
| USP-1000623 | Acebutolol Related Compound B (N-{3-Acetyl-4-[2-hydroxy-3-(isopropylamino)propoxy]phenyl}acetamide) | 20 mg |
| USP-1000699 | Acebutolol Related Compound I (N-{3-Acetyl-4-[3-(ethylamino)-2-hydroxypropoxy]phenyl}butyramide) | 20 mg |
| USP-1042420 | Atazanavir Related Compound B - Ethyl (4R)-1-[N8-nitro-L-arginyl]-4-methylpiperidine-2-carboxylate dihydrochloride | 20 mg |
| USP-1044356 | Atazanavir Related Compound A ((S)-2-[(Methoxycarbonyl)amino]-3,3-dimethylbutanoic acid) | 25 mg |
| USP-1078289 | Budesonide Related Compound L (16alpha,17-[butylidenebis(oxy)]-21-hydroxypregna-1,4-diene-3,11,20-trione) | 25 mg |
| USP-1099041 | Cephalexin Related Compound D (3-Hydroxy-4-methylthiophen-2(5H)-one) | 25 mg |
| USP-1099063 | Cephalexin Related Compound F ((6R,7R)-7-[(R)-2-Amino-2-phenylacetamido]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-3-ene-2-carboxylic acid, dihydrate) | 25 mg |
| USP-1193389 | Iscotrizinol Related Compound C (2-Ethylhexyl 4-[(4-{[4-(tert-butylcarbamoyl)phenyl]amino}-6-chloro-1,3,5-triazin-2-yl)amino]benzoate) | 25 mg |
| USP-1193390 | Iscotrizinol Related Compound D (2-Ethylhexyl 4-[(4,6-bis{[4-(tert-butylcarbamoyl)phenyl]amino}-1,3,5-triazin-2-yl)amino]benzoate) | 25 mg |
| USP-1193425 | Iscotrizinol Related Compound G (2-Ethylhexyl 4-{4-[(4-{[4-(tert-butylcarbamoyl)phenyl]amino}-6-[(4-{[(2-ethylhexyl)oxy]carbonyl}phenyl)amino]-1,3,5-triazin-2-yl)amino]benzamido}benzoate) | 25 mg |
| USP-1193447 | Iscotrizinol Related Compound I (Bis(2-ethylhexyl) 4,4'-{[6-({4-[(4-{[(2-ethylhexyl)oxy]carbonyl}phenyl)carbamoyl]phenyl}amino)-1,3,5-triazine-2,4-diyl]bis(azanediyl)}dibenzoate) | 25 mg |
| USP-1213136 | Dinoprostone Related Compound C ((E)-7-{(1R,2R,3R)-3-Hydroxy-2-[(S,E)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl}hept-5-enoic acid) | 20 mg |
| USP-1231830 | Econazole Related Compound A (1-(2,4-Dichlorophenyl)-2-(1H-imidazole-1-yl)ethanol) | 15 mg |
| USP-1231852 | Econazole Related Compound C (1-(4-Chlorobenzyl)-3-[(2RS)-2-[(4-chlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl]imidazolium chloride) | 15 mg |
| USP-1366080 | Lidocaine Related Compound H -(2-Chloro-N-(2,6-dimethylphenyl)acetamide) | 50 mg |
| USP-1367606 | Linezolid Related Compound D - ((R)-[3-(3-Fluoro-4-morpholinophenyl)-2-oxooxazolidin-5-yl]methyl methanesulfonate) | 20 mg |
| USP-1396168 | Metaxalone Related Compound B - (1-Amino-3-(3,5-dimethylphenoxy)propan-2-ol) | 25 mg |
| USP-1396171 | Metaxalone Related Compound C - (Bis[2-hydroxy-3-(3,5-dimethylphenoxy)propyl]amine) | 25 mg |
| USP-1437461 | Methyl Salicylate Related Compound A - (DimethyI4-hydroxyisophthalate) | 50 mg |
| USP-1463348 | Nicotine Related Compound C - ((S)-1-methyl-5-(pyridin-3-yl)pyrrolidin-2-one) | 20 mg |
| USP-1471517 | Norfloxacin Related Compound A - (7-Chloro-1-ethyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid) | 15 mg |
| USP-1471550 | Norfloxacin Related Compound E - (7-Chloro-1-ethyl-4-oxo-6-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid) | 15 mg |
| USP-1471583 | Norfloxacin Related Compou nd H - (7-[4-(ethoxycarbonyl)pipe razin-1-yl]-1-ethyl-6-fluoro-4-oxo-1,4-di hydroquinoline-3-carboxylic acid) | 15 mg |